Surface-Engineered Cesium Lead Bromide Perovskite Nanocrystals for Enabling Photoreduction Activity

In recent years, colloidal lead halide perovskite (LHP) nanocrystals (NCs) have exhibited such intriguing light absorption properties to be contemplated as promising candidates for photocatalytic conversions. However, for effective photocatalysis, the light harvesting system needs to be stable under the reaction conditions propaedeutic to a specific transformation. Unlike photoinduced oxidative reaction pathways, photoreductions with LHP NCs are challenging due to their scarce compatibility with common hole scavengers like amines and alcohols. In this contribution, it is investigated the potential of CsPbBr3 NCs protected by a suitably engineered bidentate ligand for the photoreduction of quinone species. Using an in situ approach for the construction of the passivating agent and a halide excess environment, quantum-confined nanocubes (average edge length = 6.0 ± 0.8 nm) are obtained with a low ligand density (1.73 ligand/nm2) at the NC surface. The bifunctional adhesion of the engineered ligand boosts the colloidal stability of the corresponding NCs, preserving their optical properties also in the presence of an amine excess. Despite their relatively short exciton lifetime (τAV = 3.7 ± 0.2 ns), these NCs show an efficient fluorescence quenching in the presence of the selected electron accepting quinones (1,4-naphthoquinone, 9,10-phenanthrenequinone, and 9,10-anthraquinone). All of these aspects demonstrate the suitability of the NCs for an efficient photoreduction of 1,4-naphthoquinone to 1,4-dihydroxynaphthalene in the presence of triethylamine as a hole scavenger. This chemical transformation is impracticable with conventionally passivated LHP NCs, thereby highlighting the potential of the surface functionalization in this class of nanomaterials for exploring new photoinduced reactivities.

Aptamer-Based Smart Targeting and Spatial Trigger-Response Drug-Delivery Systems for Anticancer Therapy

In recent years, the field of drug delivery has witnessed remarkable progress, driven by the quest for more effective and precise therapeutic interventions. Among the myriad strategies employed, the integration of aptamers as targeting moieties and stimuli-responsive systems has emerged as a promising avenue, particularly in the context of anticancer therapy. This review explores cutting-edge advancements in targeted drug-delivery systems, focusing on the integration of aptamers and stimuli-responsive platforms for enhanced spatial anticancer therapy. In the aptamer-based drug-delivery systems, we delve into the versatile applications of aptamers, examining their conjugation with gold, silica, and carbon materials. The synergistic interplay between aptamers and these materials is discussed, emphasizing their potential in achieving precise and targeted drug delivery. Additionally, we explore stimuli-responsive drug-delivery systems with an emphasis on spatial anticancer therapy. Tumor microenvironment-responsive nanoparticles are elucidated, and their capacity to exploit the dynamic conditions within cancerous tissues for controlled drug release is detailed. External stimuli-responsive strategies, including ultrasound-mediated, photo-responsive, and magnetic-guided drug-delivery systems, are examined for their role in achieving synergistic anticancer effects. This review integrates diverse approaches in the quest for precision medicine, showcasing the potential of aptamers and stimuli-responsive systems to revolutionize drug-delivery strategies for enhanced anticancer therapy.

Synthesis of novel conjugated polymers comprising modified cyclopentadithiophene units in the main chain

We have synthesized novel copolymers P1–P3 comprising fluorene units alternating with cyclopentadithiophene fragments modified at the bridge positions with cyanovinyl or imine groups. Optoelectronic properties of the polymers were investigated in solution and in solid films. A potential of using these materials in organic electronics was considered.